MASSERINI, MASSIMO ERNESTO
 Distribuzione geografica
Continente #
NA - Nord America 13.321
EU - Europa 6.899
AS - Asia 2.918
SA - Sud America 127
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 24
OC - Oceania 24
Totale 23.347
Nazione #
US - Stati Uniti d'America 12.973
CN - Cina 1.285
DE - Germania 1.273
IT - Italia 1.183
SE - Svezia 1.101
IE - Irlanda 869
SG - Singapore 751
UA - Ucraina 662
RU - Federazione Russa 483
GB - Regno Unito 420
HK - Hong Kong 339
CA - Canada 332
FI - Finlandia 230
IN - India 176
PL - Polonia 126
FR - Francia 115
VN - Vietnam 113
BR - Brasile 100
AT - Austria 86
DK - Danimarca 84
BE - Belgio 68
IR - Iran 55
NL - Olanda 54
TR - Turchia 39
BG - Bulgaria 36
ID - Indonesia 27
KR - Corea 26
EU - Europa 23
PT - Portogallo 23
JP - Giappone 22
AU - Australia 21
ES - Italia 21
CH - Svizzera 15
CZ - Repubblica Ceca 14
TW - Taiwan 14
MX - Messico 13
RO - Romania 13
ZA - Sudafrica 13
CL - Cile 11
IL - Israele 11
AR - Argentina 7
PK - Pakistan 7
EG - Egitto 6
HU - Ungheria 6
IQ - Iraq 6
MY - Malesia 6
TH - Thailandia 6
BD - Bangladesh 4
GR - Grecia 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
JO - Giordania 3
LB - Libano 3
MA - Marocco 3
MD - Moldavia 3
MO - Macao, regione amministrativa speciale della Cina 3
MU - Mauritius 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
UZ - Uzbekistan 3
YE - Yemen 3
CI - Costa d'Avorio 2
ET - Etiopia 2
JM - Giamaica 2
KE - Kenya 2
LT - Lituania 2
LV - Lettonia 2
PH - Filippine 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
CO - Colombia 1
CY - Cipro 1
GE - Georgia 1
HN - Honduras 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
MK - Macedonia 1
OM - Oman 1
PY - Paraguay 1
QA - Qatar 1
SC - Seychelles 1
Totale 23.347
Città #
Ann Arbor 2.238
Woodbridge 1.577
Chandler 1.058
Houston 864
Dublin 845
Fairfield 832
Jacksonville 751
Frankfurt am Main 712
Ashburn 613
Wilmington 610
Dearborn 596
Singapore 557
Milan 533
Seattle 385
Santa Clara 319
Hong Kong 316
New York 308
Cambridge 293
Princeton 278
Nanjing 223
Beijing 174
Shanghai 164
Lachine 127
Kraków 114
Lawrence 110
Altamura 103
Toronto 96
Helsinki 92
Vienna 85
Nanchang 82
Guangzhou 78
Council Bluffs 77
Hangzhou 69
Boardman 68
Ottawa 66
San Diego 66
Brussels 62
Dong Ket 55
Andover 51
Changsha 50
Fremont 49
Tianjin 44
Shenyang 43
Wayne 43
Falls Church 38
Hebei 36
Jiaxing 36
Jinan 36
Plovdiv 36
Mountain View 31
Nürnberg 31
Rome 28
Zhengzhou 28
Auburn Hills 27
Kunming 27
Los Angeles 27
Norwalk 24
Jakarta 23
Grafing 21
Ningbo 21
Dallas 20
Huizen 20
Redmond 20
London 19
Pune 19
Hefei 17
Chicago 16
Montréal 16
Edmonton 14
Taizhou 14
Lecco 13
New Delhi 13
Detroit 12
Munich 12
San Mateo 12
São Paulo 12
Monmouth Junction 11
Washington 11
Ahmedabad 10
Amsterdam 10
Fuzhou 10
Leawood 10
Segrate 10
Taipei 10
University Park 10
Zanjan 10
Palermo 9
Philadelphia 9
Porto 9
Brno 8
Copenhagen 8
Kiev 8
Verona 8
Como 7
Cusano Milanino 7
Duncan 7
Florence 7
Pavia 7
Rajsamand 7
Tappahannock 7
Totale 16.805
Nome #
Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-β peptide 490
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 349
Investigation of Functionalized Poly(N,N-dimethylacrylamide)-block-polystyrene Nanoparticles As Novel Drug Delivery System to Overcome the Blood-Brain Barrier in Vitro 336
Novel Antitransferrin Receptor Antibodies Improve the Blood-Brain Barrier Crossing Efficacy of Immunoliposomes 326
Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide 324
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 295
THE TOXICITY OF AMYLOID-BETA OLIGOMERS AND TAU HYPERPHOSPHORYLATION ARE PREVENTED FROM LIPID-BASED NANOPARTICLES IN HUMAN PRIMARY FIBOBLASTS 289
The ability of liposomes, tailored for blood-brain barrier targeting, to reach the brain is dramatically affected by the disease state 282
Nanomedicine for the treatment of Alzheimer's disease 270
Morphogenic effect of common solvent in the self-assembly behavior of amphiphilic PEO-b-PLA 269
Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for treatment of Alzheimer’s disease 259
Lipid-based nanoparticles counteract the oligomer abeta toxicity and tau phosphorylation in an ex-vivo biomolecular model of alzheimer disease 256
Versatile and Efficient Targeting Using a Single Nanoparticulate Platform and its Application to Cancer and Alzheimer's Disease 252
Enhanced brain targeting of engineered solid lipid nanoparticles 250
Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model 249
Evaluation of gold nanoparticles biocompatibility: a multiparametric study on cultured endothelial cells and macrophages 249
Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease 247
TrkA pathway activation induced by amyloid-beta (Abeta) 244
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 241
Characterization of prion protein-enriched domains, isolated from rat cerebellar granule cells in culture 236
Prion protein structure is affected by pH-dependent interaction with membranes: a study in a model system 235
18F-labeling syntheses and preclinical evaluation of functionalized nanoliposomes for Alzheimer's disease 234
Curcumin derivatives as new ligands of Aβ peptides 231
Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: Implications for therapy of Alzheimer disease 223
Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivation 222
Protein-functionalized nanoparticles derived from end-functional polymers and polymer prodrugs for crossing the blood-brain barrier 211
Effect of nanoparticles binding β-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages 207
Iron oxide nanoparticles surface coating and cell uptake affect biocompatibility and inflammatory responses of endothelial cells and macrophages 205
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 204
Effect of modified collagen on amyloid beta peptide aggregation 204
Abeta peptide toxicity is reduced after treatments decreasing phosphatidylethanolamine content in differentiated neuroblastoma cells 203
Developmental changes in the protein composition of sphingolipid- and cholesterol-enriched membrane domains of rat cerebellar granule cells 202
Liposomes functionalized to overcome the blood–brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model 202
Functionalized liposomes and phytosomes loading Annona muricata L. aqueous extract: Potential nanoshuttles for brain-delivery of phenolic compounds 200
Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimer Disease 199
Membrane features and activity of GPI-anchored enzymes: alkaline phosphatase reconstituted in model membranes 198
Inhibition of murine leukemia (WEHI-3B and L1210) proliferation by cholera toxin B subunit 197
Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide 196
Pin1, a new player in the fate of HIF-1α degradation: an hypothetical mechanism inside vascular damage as Alzheimer’s disease risk factor 193
Amyposomes: a nanomedicine designed for treatment of Alzheimer disease 192
Pin1: a new outlook in Alzheimer's disease 190
Immunoseparation of Prion protein-enriched domains from other detergent-resistant membrane fractions, isolated from neuronal cells 188
Interactions of proteins with ganglioside-enriched microdomains on the membrane: the lateral phase separation of molecular species of GD1a ganglioside, having homogeneous long-chain base composition, is recognized by Vibrio cholerae sialidase 187
Enhanced folate binding of cultured fibroblasts from Alzheimer's disease patients 185
Role of lipid rafts and GM1 in the segregation and processing of Prion Protein 184
Pin1 affects Tau phosphorylation in response to Abeta oligomers 179
Study of the effects of nanoliposomes engineered for the treatment of Alzheimer's disease on the electrical activity of cortical neurons 179
Beta-amyloid (25-35) enhances lipid metabolism and protein ubiquitination in cultured neurons 177
Abnormal cross-talk between mutant presenilin 1 (I143T, G384A) and glycosphingolipid biosynthesis 176
Enhanced brain targeting of engineered solid lipid nanoparticles 176
Fuc-GM1 ganglioside mimics the receptor function of GM1 for cholera toxin 174
Ceramides and sphingomyelinases in senile plaques 174
AUTOPHAGY ALTERATION UNDER ISCHEMIC CONDITION: A POSSIBLE LINK TO ALZHEIMER'S DISEASE 174
Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in alzheimer’s disease mouse models 174
Detection and Characterization of Different Brain-Derived Subpopulations of Plasma Exosomes by Surface Plasmon Resonance Imaging 173
Lipid-based nanoparticles with high binding affinity for amyloid-b1e42 peptide 170
THE TOXIC EFFECT OF ABETA OLIGOMERS MAY BE REDUCED BY LIPID-BASED NANOPARTICLES IN HUMAN EX-VIVO MODELS 170
Two tail-anchored protein variants, differing in transmembrane domain length and intracellular sorting, interact differently with lipids 169
mApoE-Functionalized Nanoliposomes Delivering Doxorubicin and Ultrasmall Superparamagnetic Iron Oxide to Glioblastoma Cells Characterized by TEM and Confocal Microscopy 169
ALCOHOL AND NEURAL LIPIDS 168
Age-related changes in the ceramide composition of the major gangliosides present in rat brain subcellular fractions enriched in plasma membranes of neuronal and myelin origin 168
Enhanced GM1 ganglioside catabolism in cultured fibroblasts from Alzheimer patients 167
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 167
A nanomedicine-based therapeutic approach restores memory and ameliorates amyloid pathology in Alzheimer's mouse models 166
Dependence of rat liver CMP-N-acetylneuraminate:GM1 sialyltransferase (SAT IV) activity on the ceramide composition of GM1 ganglioside 165
Role of phosphatidylethanol in membranes. Effects on membrane fluidity, tolerance to ethanol, and activity of membrane-bound enzymes 164
Attempt of neuroprotective response of rat cultured hippocampal neurons against Abeta insult 164
Liposomes functionalized with acidic lipids rescue Aβ-induced toxicity in murine neuroblastoma cells 163
The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue 162
A surveillance system for early-stage diagnosis of endogenous diseases by swarms of nanobots 160
Ischemic conditions and β-secretase activation: The impact of membrane cholesterol enrichment as triggering factor in rat brain endothelial cells 160
Lipid-based nanoparticles as a potential tool to deplete abeta. Toward new therapeutic strategies for Alzheimer’s disease? 159
A photo-reactive derivative of ganglioside GM1 specifically cross-links VIP21-caveolin on the cell surface 158
Nanotechnology for neurodegenerative disorders 158
Nanomedicine for the treatment of Alzheimer's disease 158
Thermotropic behavior of fatty acid ethyl esters in phospholipid liposomes 157
Early-Stage Diagnosis of Endogenous Diseases by Swarms of Nanobots: An Applicative Scenario 153
Methyl-β-cyclodextrin treatment affects the thermotropic behaviour of membranes and detergent-resistant membrane fractions of cultured A431 cells 153
Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice 153
Palmitic is the main fatty acid carried by lipids of detergent-resistant membrane fractions from neural and non-neural cells 152
Influence of glycolipid oligosaccharide and long-chain base composition on the thermotropic properties of dipalmitoylphosphatidylcholine large unilamellar vesicles containing gangliosides 152
Nanotechnology for neurodegenerative disorders 152
Effect of curcumin-associated and lipid ligand functionalised nanoliposomes on aggregation of the Alzheimer's Aβ peptide 151
A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1 Delta E9 Mouse Model of Alzheimer's Disease 151
Changes in the composition of detergent-resistant membrane domains of cultured neurons following protein kinase C activation 151
Synthesis of functionalized [F-18]liposomes for preclinical PET imaging in Alzheimer's disease 149
New tricyclic compounds, process for their manufacture and their use as ligands of beta-alyloid peptides 148
Association to HeLa cells and surface behavior of exogenous gangliosides studied with a fluorescent derivative of GM1 148
Preparation and use of liposomes for the study of sphingolipid segregation in membrane model systems 145
Stability of Aβ (1-42) peptide fibrils as consequence of environmental modifications 144
Nanoparticle-based strategy to cross the BBB: the potential for the therapy of Alzheimer’s disease 144
Functionalization with curcumin-derivative and TAT peptide enhances the interaction with human brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide 142
Lipid-based nanoparticles (NPs) with high binding affinity for amyloid-beta1-42 peptide modulate the barrier properties of a monolayer of endothelial cells 141
Multi-functional liposomes prevent memory impairment and slow down brain B-amyloid deposition in a mouse model of Alzheimer’s disease. 139
Self-assembled electrical biodetector based on reduced graphene oxide 137
Proteomics of plasma membrane microdomains 136
Liposomes functionalized with GT1b ganglioside with high affinity for amyloid beta-peptide 136
Binding of lipid-based nanoparticles to plasma abeta: relevance for new therapeutic strategies in Alzheimer’s disease 136
Raman spectroscopy uncovers biochemical tissue-related features of extracellular vesicles from mesenchymal stromal cells 136
Nuovi composti triciclici glicofusi, procedimento per la loro produzione e loro impiego quali ligandi dei peptidi β amiloidi (Aβ) 135
Totale 19.487
Categoria #
all - tutte 78.441
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.441


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.228 0 0 0 0 0 0 0 301 383 211 263 70
2020/20212.536 227 153 286 288 204 165 269 153 236 258 96 201
2021/20221.838 98 167 176 189 76 175 142 100 104 169 158 284
2022/20233.854 449 1.198 338 396 230 562 37 220 260 25 86 53
2023/20242.561 66 84 137 146 328 678 554 121 158 33 37 219
2024/20252.314 244 541 267 214 430 210 259 149 0 0 0 0
Totale 24.035